| Year |
Citation |
Score |
| 2007 |
Kusek GK, Wahlsten D, Herron BJ, Bolivar VJ, Flaherty L. Localization of two new X-linked quantitative trait loci controlling corpus callosum size in the mouse. Genes, Brain, and Behavior. 6: 359-63. PMID 16899052 DOI: 10.1111/j.1601-183X.2006.00264.x |
0.357 |
|
| 2003 |
McFadyen MP, Kusek G, Bolivar VJ, Flaherty L. Differences among eight inbred strains of mice in motor ability and motor learning on a rotorod. Genes, Brain, and Behavior. 2: 214-9. PMID 12953787 DOI: 10.1034/j.1601-183X.2003.00028.x |
0.312 |
|
| 2003 |
Downing C, Rodd-Henricks KK, Flaherty L, Dudek BC. Genetic analysis of the psychomotor stimulant effect of ethanol. Genes, Brain, and Behavior. 2: 140-51. PMID 12931787 DOI: 10.1034/j.1601-183X.2003.00022.x |
0.343 |
|
| 2003 |
Cogswell C, Price SJ, Hou X, Guay-Woodford LM, Flaherty L, Bryda EC. Positional cloning of jcpk/bpk locus of the mouse. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 14: 242-9. PMID 12682776 DOI: 10.1007/S00335-002-2241-0 |
0.312 |
|
| 2001 |
Bolivar VJ, Pooler O, Flaherty L. Inbred strain variation in contextual and cued fear conditioning behavior. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 12: 651-6. PMID 11471061 DOI: 10.1007/s003350020039 |
0.322 |
|
| 2000 |
Bolivar VJ, Caldarone BJ, Reilly AA, Flaherty L. Habituation of activity in an open field: A survey of inbred strains and F1 hybrids. Behavior Genetics. 30: 285-93. PMID 11206083 DOI: 10.1023/A:1026545316455 |
0.585 |
|
| 1997 |
Caldarone B, Saavedra C, Tartaglia K, Wehner JM, Dudek BC, Flaherty L. Quantitative trait loci analysis affecting contextual conditioning in mice. Nature Genetics. 17: 335-7. PMID 9354801 DOI: 10.1038/Ng1197-335 |
0.601 |
|
| 1997 |
Kuster JE, Guarnieri MH, Ault JG, Flaherty L, Swiatek PJ. IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 8: 673-81. PMID 9271670 DOI: 10.1007/s003359900535 |
0.335 |
|
| 1997 |
Bryda EC, Ling H, Flaherty L. A high-resolution genetic map around waltzer on mouse chromosome 10 and identification of a new allele of waltzer. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 8: 1-4. PMID 9021139 DOI: 10.1007/s003359900336 |
0.342 |
|
| 1996 |
Bryda EC, Ling H, Rathbun DE, Burmeister M, Flaherty L. Fine genetic map of mouse chromosome 10 around the polycystic kidney disease gene, jcpk, and ankyrin 3. Genomics. 35: 425-30. PMID 8812475 DOI: 10.1006/geno.1996.0381 |
0.349 |
|
| 1990 |
Widacki SM, Mehta V, Flaherty L, Cook RG. Biochemical differences in Qa-2 antigens expressed by Qa-2+,6+ and Qa-2+,6- strains. Evidence for differential expression of the Q7 and Q9 genes. Molecular Immunology. 27: 559-70. PMID 2381428 DOI: 10.1016/0161-5890(90)90075-B |
0.366 |
|
| 1988 |
Singer DS, Hare J, Golding H, Flaherty L, Rudikoff S. Characterization of a new subfamily of class I genes in the H-2 complex of the mouse. Immunogenetics. 28: 13-21. PMID 3378834 DOI: 10.1007/Bf00372524 |
0.348 |
|
| 1987 |
Warner CM, Gollnick SO, Flaherty L, Goldbard SB. Analysis of Qa-2 antigen expression by preimplantation mouse embryos: possible relationship to the preimplantation-embryo-development (Ped) gene product. Biology of Reproduction. 36: 611-6. PMID 3593833 DOI: 10.1095/Biolreprod36.3.611 |
0.347 |
|
| 1986 |
O'Neill AE, Reid K, Garberi JC, Karl M, Flaherty L. Extensive deletions in the Q region of the mouse major histocompatibility complex. Immunogenetics. 24: 368-73. PMID 3025084 DOI: 10.1007/Bf00377954 |
0.307 |
|
| 1986 |
Michaelson J, Boyse EA, Ciccia L, Flaherty L, Fleissner E, Garnick E, Hämmerling U, Lawrence M, Mauch P, Shen FW. Biochemical genetics of TL antigens. Immunogenetics. 24: 103-14. PMID 2427440 DOI: 10.1007/Bf00373117 |
0.375 |
|
| 1985 |
Flaherty L, DiBiase K, Lynes MA, Seidman JG, Weinberger O, Rinchik EM. Characterization of a Q subregion gene in the murine major histocompatibility complex. Proceedings of the National Academy of Sciences of the United States of America. 82: 1503-7. PMID 2983348 DOI: 10.1073/Pnas.82.5.1503 |
0.355 |
|
| 1984 |
Lynes MA, Flaherty L, Michaelson J, Collins JJ, Rinchik EM. Allogeneic reactivity in normal mouse serum. Journal of Immunogenetics. 11: 189-96. PMID 6520407 DOI: 10.1111/J.1744-313X.1984.Tb01056.X |
0.371 |
|
| 1984 |
Sharrow SO, Flaherty L, Sachs DH. Serologic cross-reactivity between Class I MHC molecules and an H-2-linked differentiation antigen as detected by monoclonal antibodies. The Journal of Experimental Medicine. 159: 21-40. PMID 6363595 DOI: 10.1084/Jem.159.1.21 |
0.368 |
|
| 1984 |
Flaherty L, Lynes MA. Use of monoclonal antibodies in the study of the fine specificity of antigens coded for by the major histocompatibility complex in mice. Methods in Enzymology. 108: 481-94. PMID 6084800 DOI: 10.1016/S0076-6879(84)08113-1 |
0.346 |
|
| 1983 |
Shin HS, Flaherty L, Artzt K, Bennett D, Ravetch J. Inversion in the H-2 complex of t-haplotypes in mice. Nature. 306: 380-3. PMID 6316154 DOI: 10.1038/306380a0 |
0.353 |
|
| 1982 |
Michaelson J, Tung JS, Flaherty L, Hämmerling U, Bushkin Y. The biochemical genetics of TL antigens on mouse thymocytes. European Journal of Immunology. 12: 257-61. PMID 6980119 DOI: 10.1002/eji.1830120402 |
0.348 |
|
| 1982 |
Lindahl KF, Hausmann B, Flaherty L. Polymorphism of a Qa-1-associated antigen defined by cytotoxic T cells. I. Qed-1a and Qed-1d. European Journal of Immunology. 12: 159-66. PMID 6978819 DOI: 10.1002/eji.1830120211 |
0.351 |
|
| 1982 |
Rudofsky UH, Dilwith RL, Lynes M, Flaherty L. Murine monoclonal antikidney autoantibodies. I. Anti-renal proximal tubular basement membrane autoantibodies. Clinical Immunology and Immunopathology. 25: 165-78. PMID 6187505 DOI: 10.1016/0090-1229(82)90179-9 |
0.309 |
|
| 1982 |
Plate JM, McDaniel CA, Flaherty L, Stimpfling JH, Melvold RW, Martin NQ. Antigen-specific soluble helper activity for murine major histocompatibility complex-encoded molecules. I. Kinetics of factor production after skin transplantation and genetic mapping of the H-2 region specificity. The Journal of Experimental Medicine. 155: 681-97. PMID 6174663 DOI: 10.1084/Jem.155.3.681 |
0.365 |
|
| 1981 |
Flaherty L, Rinchik E, DiBiase K. New complexities at the Qa-1 locus. Immunogenetics. 13: 339-46. PMID 6792068 DOI: 10.1007/BF00364499 |
0.373 |
|
| 1981 |
Michaelson J, Flaherty L, Bushkin Y, Yudkowitz H. Further biochemical data on Qa-2. Immunogenetics. 14: 129-40. PMID 6173317 DOI: 10.1007/BF00344306 |
0.331 |
|
| 1979 |
Flaherty L, Zimmerman D, Wachtel SS. H-Y antigen. Cell surface mapping and testosterone-induced supramolecular repatterning. The Journal of Experimental Medicine. 150: 1020-7. PMID 512582 DOI: 10.1084/Jem.150.4.1020 |
0.341 |
|
| 1979 |
Hämmerling GJ, Hämmerling U, Flaherty L. Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodies. The Journal of Experimental Medicine. 150: 108-16. PMID 312902 DOI: 10.1084/Jem.150.1.108 |
0.374 |
|
| 1979 |
Flaherty L, Zimmerman D. Surface mapping of mouse thymocytes. Proceedings of the National Academy of Sciences of the United States of America. 76: 1990-3. PMID 88052 DOI: 10.1073/Pnas.76.4.1990 |
0.306 |
|
| 1979 |
Sullivan K, Flaherty L. A new H-2 recombinant strain, B6.AK1 -H-2ozl: Skin graft and MLC experiments Immunogenetics. 9: 101-104. DOI: 10.1007/BF01570397 |
0.321 |
|
| 1978 |
Eicher EM, Cherry M, Flaherty L. Autosomal phosphoglycerate kinase linked to mouse major histocompatibility complex. Molecular & General Genetics : Mgg. 158: 225-8. PMID 628373 DOI: 10.1007/BF00267193 |
0.366 |
|
| 1978 |
Flaherty L, Rinchik E. No evidence for foreign H-2 specificities on the EL4 mouse lymphoma. Nature. 273: 52-3. PMID 567747 DOI: 10.1038/273052a0 |
0.354 |
|
| 1978 |
Zinkernagel RM, Althage A, Cooper S, Kreeb G, Klein PA, Sefton B, Flaherty L, Stimpfling J, Shreffler D, Klein J. Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness. The Journal of Experimental Medicine. 148: 592-606. PMID 212503 DOI: 10.1084/Jem.148.2.592 |
0.355 |
|
| 1978 |
Klein J, Flaherty L, VandeBerg JL, Shreffler DC. H-2 haplotypes, genes, regions, and antigens: First listing Immunogenetics. 6: 489-512. DOI: 10.1007/BF01563941 |
0.356 |
|
| 1978 |
Flaherty L, Zimmerman D, Hansen TH. Further serological analysis of the Qa antigens: Analysis of an anti-H-2.28 serum Immunogenetics. 6: 245-251. DOI: 10.1007/BF01563914 |
0.344 |
|
| 1977 |
Hansen TH, Cullen SE, Melvold R, Kohn H, Flaherty L, Sachs DH. Mutation in a new H-2-associated histocompatibility gene closely linked to H-2D. The Journal of Experimental Medicine. 145: 1550-8. PMID 68094 DOI: 10.1084/jem.145.6.1550 |
0.387 |
|
| 1976 |
Flaherty L. The Tla region of the mouse: Identification of a new serologically defined locus, Qa-2 Immunogenetics. 3: 533-539. DOI: 10.1007/BF01576983 |
0.318 |
|
| 1975 |
Flaherty L. H-33-A histocompatibility locus to the left of the H-2 complex Immunogenetics. 2: 325-329. DOI: 10.1007/BF01572301 |
0.353 |
|
| 1975 |
Flaherty L, Wachtel SS. H(Tla) system: Identification of two new loci, H-31 and H-32, and alleles Immunogenetics. 2: 81-85. DOI: 10.1007/BF01572277 |
0.323 |
|
| 1973 |
Flaherty L, Bennett D. Histoincompatibilities found between congenic strains which differ at loci determing differentiation antigens. Transplantation. 16: 505-14. PMID 4584957 DOI: 10.1097/00007890-197311000-00016 |
0.327 |
|
| 1972 |
Boyse EA, Flaherty L, Stockert E, Old LJ. Histoincompatibility attributable to genes near H-2 that are not revealed by hemagglutination or cytotoxicity tests. Transplantation. 13: 431-2. PMID 4552366 DOI: 10.1097/00007890-197204000-00013 |
0.312 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1996 |
Guay-Woodford LM, Bryda EC, Christine B, Lindsey JR, Collier WR, Avner ED, D'Eustachio P, Flaherty L. Evidence that two phenotypically distinct mouse PKD mutations, bpk and jcpk, are allelic. Kidney International. 50: 1158-65. PMID 8887273 DOI: 10.1038/Ki.1996.423 |
0.3 |
|
| 1993 |
Rinchik EM, Flaherty L, Russell LB. High-frequency induction of chromosomal rearrangements in mouse germ cells by the chemotherapeutic agent chlorambucil. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 15: 831-6. PMID 8141802 DOI: 10.1002/bies.950151210 |
0.3 |
|
| 1993 |
Wang Q, Geliebter J, Tonkonogy S, Flaherty L. Expression of the Q2 gene of the MHC in thymus and intestinal epithelial cells. Immunogenetics. 38: 370-2. PMID 8344724 DOI: 10.1007/BF00210481 |
0.292 |
|
| 1983 |
Michaelson J, Rosenson RS, Reinisch CL, Flaherty L. Biochemical isolation of Qa-2 molecules expressed on Qa-2+ leukemias arising in Qa-2- mice. Immunogenetics. 18: 155-7. PMID 6885119 DOI: 10.1007/BF00368544 |
0.292 |
|
| 1999 |
Manley K, Shirley TL, Flaherty L, Messer A. Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nature Genetics. 23: 471-3. PMID 10581038 DOI: 10.1038/70598 |
0.29 |
|
| 1980 |
Flaherty L, Rinchik E. A new allele and antigen at the Tla locus. Immunogenetics. 11: 205-8. PMID 6157647 DOI: 10.1007/BF01567786 |
0.288 |
|
| 1992 |
Pamer EG, Wang CR, Flaherty L, Lindahl KF, Bevan MJ. H-2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell. 70: 215-23. PMID 1353418 DOI: 10.1016/0092-8674(92)90097-V |
0.283 |
|
| 1984 |
Watson AL, Mahoney RJ, D'Amico SA, Coviello LJ, Flaherty L, Yunis EJ. Utilization of murine peripheral blood lymphocytes for H-2 typing. Tissue Antigens. 24: 150-4. PMID 6515631 DOI: 10.1111/J.1399-0039.1984.Tb02119.X |
0.281 |
|
| 1991 |
Waters JB, Flaherty L. Expression and regulation of Q8b in a transfected cell line. Immunogenetics. 34: 179-84. PMID 1654299 DOI: 10.1007/BF00205821 |
0.279 |
|
| 1977 |
Artzt K, Hamburger L, Flaherty L. H-39, a histocompatibility locus closely linked to the T/t complex Immunogenetics. 5: 477-480. DOI: 10.1007/Bf01570507 |
0.271 |
|
| 2003 |
Bolivar V, Flaherty L. A region on chromosome 15 controls intersession habituation in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 9435-8. PMID 14561872 |
0.271 |
|
| 1982 |
Lynes MA, Karl M, DiBiase K, Flaherty L. Supramolecular relationships of membrane antigens on the murine thymocyte. Journal of Immunogenetics. 9: 475-84. PMID 6131095 DOI: 10.1111/J.1744-313X.1982.Tb01009.X |
0.266 |
|
| 1994 |
Yu YY, Forman J, Aldrich C, Blazar B, Flaherty L, Kumar V, Bennett M. Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells. International Immunology. 6: 1297-306. PMID 7529556 DOI: 10.1093/Intimm/6.9.1297 |
0.266 |
|
| 1994 |
Montgomery JC, Guarnieri MH, Tartaglia KE, Flaherty LA. High-resolution genetic map and YAC contig around the mouse neurological locus reeler. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 5: 756-61. PMID 7894155 DOI: 10.1007/BF00292008 |
0.265 |
|
| 1998 |
Herron BJ, Silva GH, Flaherty L. Putative assignment of ESTs to the genetic map by use of the SSLP database. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 9: 1072-4. PMID 9880682 DOI: 10.1007/S003359900929 |
0.265 |
|
| 2006 |
de Ledesma AM, Desai AN, Bolivar VJ, Symula DJ, Flaherty L. Two new behavioral QTLs, Emo4 and Reb1, map to mouse Chromosome 1: Congenic strains and candidate gene identification studies. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 17: 111-8. PMID 16465591 DOI: 10.1007/s00335-005-0107-y |
0.262 |
|
| 1995 |
Mathew PA, Kumar V, Bennett M, Flaherty L. Identification of a recombinational breakpoint at the BAT5 locus in three intra-H-2 recombinant inbred mouse strains. Experimental and Clinical Immunogenetics. 12: 261-7. PMID 8919359 |
0.258 |
|
| 2001 |
Bolivar VJ, Cook MN, Flaherty L. Mapping of quantitative trait loci with knockout/congenic strains. Genome Research. 11: 1549-52. PMID 11544198 DOI: 10.1101/gr.194001 |
0.255 |
|
| 1983 |
Cook RG, Jenkins RN, Flaherty L, Rich RR. The Qa-1 alloantigens. II. Evidence for the expression of two Qa-1 molecules by the Qa-1d genotype and for cross-reactivity between Qa-1 and H-2K. Journal of Immunology (Baltimore, Md. : 1950). 130: 1293-9. PMID 6822734 |
0.252 |
|
| 1986 |
Messer A, Flaherty L. Autosomal dominance in a late-onset motor neuron disease in the mouse. Journal of Neurogenetics. 3: 345-55. PMID 3783318 DOI: 10.3109/01677068609106858 |
0.246 |
|
| 1982 |
Margulies DH, Evans GA, Flaherty L, Seidman JG. H-2-like genes in the Tla region of mouse chromosome 17. Nature. 295: 168-70. PMID 6276757 DOI: 10.1038/295168a0 |
0.246 |
|
| 1982 |
Michaelson J, Flaherty L, Hutchinson B, Yudkowitz H. Qa-2 does not display structural genetic polymorphism detectable on isoelectric-focusing gels. Immunogenetics. 16: 363-6. PMID 7174001 DOI: 10.1007/BF00372308 |
0.245 |
|
| 1973 |
Flaherty L, Bennett D. The unusual fate of second skin grafts across an H(Tla) barrier. Transplantation. 16: 682-4. PMID 4585394 DOI: 10.1097/00007890-197312000-00026 |
0.242 |
|
| 1981 |
Soloski MJ, Vitetta ES, Flaherty L, Uhr JW. Biochemical analysis of an MHC-linked hematopoietic cell surface antigen, Qa-2. Journal of Supramolecular Structure and Cellular Biochemistry. 16: 167-77. PMID 7299842 DOI: 10.1002/jsscb.1981.380160207 |
0.242 |
|
| 2002 |
Price SJ, Chittenden LR, Flaherty L, O'Dell B, Guay-Woodford LM, Stubbs L, Bryda EC. Characterization of the region containing the jcpk PKD gene on mouse Chromosome 10. Cytogenetic and Genome Research. 98: 61-6. PMID 12584442 DOI: 10.1159/000068534 |
0.24 |
|
| 1977 |
Michaelson J, Flaherty L, Vitetta E, Poulik MD. Molecular similarities between the Qa-2 alloantigen and other gene products of the 17th chromosome of the mouse. The Journal of Experimental Medicine. 145: 1066-70. PMID 858995 |
0.238 |
|
| 1981 |
Soloski MJ, Uhr JW, Flaherty L, Vitetta ES. Qa-2, H-2K, and H-2D alloantigens evolved from a common ancestral gene. The Journal of Experimental Medicine. 153: 1080-93. PMID 6788884 |
0.235 |
|
| 1978 |
Forman J, Flaherty L. Identification of a new CML target antigen controlled by a gene associated with the Qa-2 locus Immunogenetics. 6: 227-233. DOI: 10.1007/BF01563912 |
0.231 |
|
| 1989 |
Elliott E, Rathbun D, Ramsingh A, Garberi J, Flaherty L. Genetics and expression of the Q6 and Q8 genes. An LTR-like sequence in the 3' untranslated region. Immunogenetics. 29: 371-9. PMID 2731964 DOI: 10.1007/BF00375865 |
0.229 |
|
| 1988 |
Flaherty L. Major histocompatibility complex polymorphism: a nonimmune theory for selection. Human Immunology. 21: 3-13. PMID 3284855 DOI: 10.1016/0198-8859(88)90076-6 |
0.216 |
|
| 2002 |
Guarnieri MH, Cacheiro NL, Rudofsky UH, Montgomery JC, Collins DN, Flaherty LA. A chromosomal translocation causing multiple abnormalities including open eyelids at birth and glomerulonephritis. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 13: 416-22. PMID 12226706 DOI: 10.1007/s00335-002-2161-z |
0.216 |
|
| 1990 |
Tine JA, Walsh A, Rathbun D, Leonard L, Wakeland EK, Dilwith R, Flaherty L. Genetic polymorphisms of Q region genes from wild-derived mice: implications for Q region evolution. Immunogenetics. 31: 315-25. PMID 2370077 |
0.208 |
|
| 1998 |
Qu S, Tucker SC, Ehrlich JS, Levorse JM, Flaherty LA, Wisdom R, Vogt TF. Mutations in mouse Aristaless-like4 cause Strong's luxoid polydactyly. Development (Cambridge, England). 125: 2711-21. PMID 9636085 |
0.201 |
|
| 1985 |
Widacki SM, Flaherty L, Cook RG. Biochemical characterization of the molecules reactive with Qa-6 antiserum and the monoclonal antibody 20-8-4: evidence for structural similarity with the Qa-2 molecule. Journal of Immunology (Baltimore, Md. : 1950). 135: 3333-9. PMID 2413118 |
0.194 |
|
| 1981 |
Cook RG, Rich RR, Flaherty L. The Qa-1 alloantigens. I. Identification and molecular weight characterization of glycoproteins controlled by the Qa-1a and Qa-1b alleles. Journal of Immunology (Baltimore, Md. : 1950). 127: 1894-8. PMID 6170678 |
0.194 |
|
| 1990 |
Klein J, Benoist C, David CS, Demant P, Lindahl KF, Flaherty L, Flavell RA, Hämmerling U, Hood LE, Hunt SW. Revised nomenclature of mouse H-2 genes. Immunogenetics. 32: 147-9. PMID 2228044 DOI: 10.1007/Bf02114967 |
0.188 |
|
| 1991 |
Milligan GN, Flaherty L, Braciale VL, Braciale TJ. Nonconventional (TL-encoded) major histocompatibility complex molecules present processed viral antigen to cytotoxic T lymphocytes. The Journal of Experimental Medicine. 174: 133-8. PMID 1905336 DOI: 10.1084/Jem.174.1.133 |
0.187 |
|
| 1982 |
Forman J, Trial J, Tonkonogy S, Flaherty L. The Qa2 subregion controls the expression of two antigens recognized by H-2-unrestricted cytotoxic T cells. The Journal of Experimental Medicine. 155: 749-67. PMID 6174664 |
0.186 |
|
| 1991 |
Uehara H, Abe K, Flaherty L, Bennett D, Artzt K. Molecular organization of the D-Qa region of t-haplotypes suggests that recombination is an important mechanism for generating genetic diversity of the major histocompatibility complex. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 1: 92-9. PMID 1686840 DOI: 10.1007/BF02443784 |
0.185 |
|
| 1996 |
Wang Q, Flaherty L. Developmental expression of the mouse MHC Q genes. European Journal of Immunogenetics : Official Journal of the British Society For Histocompatibility and Immunogenetics. 23: 121-7. PMID 8732475 |
0.184 |
|
| 1999 |
Ji W, Herron B, Jones JM, Jenkins NA, Gilbert DJ, Copeland NG, Swank R, Flaherty L, Meisler MH. Identification of genes within the Krd deletion on mouse chromosome 19. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 10: 399-401. PMID 10087301 DOI: 10.1007/S003359901010 |
0.183 |
|
| 2001 |
Cook MN, Williams RW, Flaherty L. Anxiety-related behaviors in the elevated zero-maze are affected by genetic factors and retinal degeneration. Behavioral Neuroscience. 115: 468-76. PMID 11345971 DOI: 10.1037//0735-7044.115.2.468 |
0.174 |
|
| 1995 |
Flaherty L, Bryda EC, Collins D, Rudofsky U, Montogomery JC. New mouse model for polycystic kidney disease with both recessive and dominant gene effects. Kidney International. 47: 552-8. PMID 7723240 |
0.174 |
|
| 2002 |
Cook MN, Bolivar VJ, McFadyen MP, Flaherty L. Behavioral differences among 129 substrains: implications for knockout and transgenic mice. Behavioral Neuroscience. 116: 600-11. PMID 12148927 DOI: 10.1037/0735-7044.116.4.600 |
0.172 |
|
| 2003 |
Williams RW, Flaherty L, Threadgill DW. The math of making mutant mice. Genes, Brain, and Behavior. 2: 191-200. PMID 12953785 DOI: 10.1034/j.1601-183X.2003.00017.x |
0.166 |
|
| 1977 |
Flaherty L, Sullivan K, Zimmerman D. The Tla locus: a new allele and antigenic specificity. Journal of Immunology (Baltimore, Md. : 1950). 119: 571-5. PMID 69663 |
0.166 |
|
| 1995 |
Jones EP, Xiao H, Schultz RA, Flaherty L, Trachtulec Z, Vincek V, Larin Z, Lehrach H, Lindahl KF. MHC class I gene organization in > 1.5-Mb YAC contigs from the H2-M region. Genomics. 27: 40-51. PMID 7665183 DOI: 10.1006/geno.1995.1006 |
0.16 |
|
| 1982 |
Rosenson RS, Flaherty L, Levine H, Reinisch CL. Repeated isolation of unique Qa2+ Ia+ clonally derived cell lines from Qa2- mice. Journal of Immunology (Baltimore, Md. : 1950). 129: 382-7. PMID 6979571 |
0.158 |
|
| 1977 |
Flaherty L, Cantor L, Zimmerman D, Bennett D. Cell surface antigens on erythroid cells. A comparison of normal and anemic (W/W) mice. Developmental Biology. 59: 237-40. PMID 892229 DOI: 10.1016/0012-1606(77)90257-3 |
0.158 |
|
| 1978 |
Michaelson J, Flaherty L, Vitetta E, Boyse EA. Biochemical demonstration- of anti-Qa activity in an H-2.28 public specificity antiserum. Immunogenetics. 7: 265-9. PMID 21302081 DOI: 10.1007/Bf01844014 |
0.157 |
|
| 1991 |
Walsh AC, Slack J, Flaherty L. Characterization of several new MHC congenic strains. Immunogenetics. 33: 290-3. PMID 1673964 DOI: 10.1007/BF00230509 |
0.157 |
|
| 1980 |
McIntyre KR, Vitetta ES, Hämmerling U, Michaelson J, Flaherty L, Uhr JW. Analysis of thymus-leukemia (TL) antigens with monoclonal antibodies. Journal of Immunology (Baltimore, Md. : 1950). 125: 601-5. PMID 7391571 |
0.156 |
|
| 1996 |
Baldocchi RA, Tartaglia KE, Bryda EC, Flaherty L. Recovery of probes linked to the jcpk locus on mouse chromosome 10 by the use of an improved representational difference analysis technique. Genomics. 33: 193-8. PMID 8660967 DOI: 10.1006/geno.1996.0183 |
0.156 |
|
| 1987 |
Elliott E, Karl M, Flaherty L. Novel mRNA species from a Q-subregion class-I gene of the murine major histocompatibility complex. Gene. 61: 189-98. PMID 3443307 DOI: 10.1016/0378-1119(87)90113-2 |
0.149 |
|
| 1980 |
Kincade PW, Flaherty L, Lee G, Watanabe T, Michaelson J. Qa antigen expression on functional lymphoid, myeloid, and stem cells in adult mice. Journal of Immunology (Baltimore, Md. : 1950). 124: 2879-85. PMID 6966299 |
0.146 |
|
| 2000 |
Bolivar V, Cook M, Flaherty L. List of transgenic and knockout mice: behavioral profiles. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 11: 260-74. PMID 10754101 DOI: 10.1007/S003350010051 |
0.146 |
|
| 1983 |
Flaherty L. Frontiers in immunogenetics edited by William H. Hildemann, Elsevier/North-Holland, 1981. $45.00/Dfl. 100.00 (xiii + 268 pages) ISBN 0 444 00624 9. Immunology Today. 4: 203. PMID 25289834 DOI: 10.1016/0167-5699(83)90088-9 |
0.142 |
|
| 1998 |
Robinson PJ, Travers PJ, Stackpoole A, Flaherty L, Djaballah H. Maturation of Qa-1b class I molecules requires beta 2-microglobulin but is TAP independent. Journal of Immunology (Baltimore, Md. : 1950). 160: 3217-24. PMID 9531277 |
0.137 |
|
| 1999 |
Herron BJ, Bryda EC, Heverly SA, Collins DN, Flaherty L. Scraggly, a new hair loss mutation on mouse chromosome 19. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 10: 864-9. PMID 10441736 |
0.136 |
|
| 1990 |
Flaherty L, Elliott E, Tine JA, Walsh AC, Waters JB. Immunogenetics of the Q and TL regions of the mouse. Critical Reviews in Immunology. 10: 131-75. PMID 2076187 |
0.133 |
|
| 2003 |
Abiola O, Angel JM, Avner P, Bachmanov AA, Belknap JK, Bennett B, Blankenhorn EP, Blizard DA, Bolivar V, Brockmann GA, Buck KJ, Bureau JF, Casley WL, Chesler EJ, Cheverud JM, ... ... Flaherty L, et al. The nature and identification of quantitative trait loci: a community's view. Nature Reviews. Genetics. 4: 911-6. PMID 14634638 DOI: 10.1038/Nrg1206 |
0.131 |
|
| 1983 |
Michaelson J, Boyse EA, Chorney M, Flaherty L, Fleissner E, Hämmerling U, Reinisch C, Rosenson R, Shen FW. The biochemical genetics of the Qa-Tla region. Transplantation Proceedings. 15: 2033-8. PMID 6673205 |
0.128 |
|
| 1972 |
Flaherty L, Bennett D, Graef S. Genetic control of nucleolar number in mouse. Experimental Cell Research. 70: 13-6. PMID 5008395 DOI: 10.1016/0014-4827(72)90175-9 |
0.127 |
|
| 1996 |
Stevens C, Flaherty L. Evidence for antigen presentation by the class Ib molecule, Qa-1 Research in Immunology. 147: 286-290. DOI: 10.1016/0923-2494(96)89641-6 |
0.126 |
|
| 1996 |
Stevens C, Flaherty L. Evidence foe antigen presentation by the class Ib molecule, Qa-1. Research in Immunology. 147: 286-90. PMID 8876056 |
0.126 |
|
| 1995 |
Meyskens FL, Kopecky KJ, Taylor CW, Noyes RD, Tuthill RJ, Hersh EM, Feun LG, Doroshow JH, Flaherty LE, Sondak VK. Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study. Journal of the National Cancer Institute. 87: 1710-3. PMID 7473820 DOI: 10.1093/Jnci/87.22.1710 |
0.121 |
|
| 1978 |
Flaherty L, Zimmerman D, Sullivan KA. Qa-2 and Qa-3 antigens on lymphocyte subpopulations. I. Mitogen responsiveness. Journal of Immunology (Baltimore, Md. : 1950). 121: 1640-3. PMID 712060 |
0.119 |
|
| 1987 |
Stiernberg J, Low MG, Flaherty L, Kincade PW. Removal of lymphocyte surface molecules with phosphatidylinositol-specific phospholipase C: effects on mitogen responses and evidence that ThB and certain Qa antigens are membrane-anchored via phosphatidylinositol. Journal of Immunology (Baltimore, Md. : 1950). 138: 3877-84. PMID 2953793 |
0.117 |
|
| 1977 |
Flaherty L, Stanton TH, Boyse EA. Contamination of Ia antiserum A.TL anti-A.TH with antibodies related to the T1a region Immunogenetics. 4: 101-103. DOI: 10.1007/Bf01575649 |
0.116 |
|
| 2002 |
Sosman JA, Unger JM, Liu PY, Flaherty LE, Park MS, Kempf RA, Thompson JA, Terasaki PI, Sondak VK. Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2067-75. PMID 11956267 DOI: 10.1200/JCO.2002.08.072 |
0.116 |
|
| 1979 |
Sullivan KA, Flaherty L. The Qa-2 antigen on lymphocyte subpopulations. Mixed lymphocyte culture and cell-mediated lympholysis. Journal of Immunology (Baltimore, Md. : 1950). 123: 2920-4. PMID 159324 |
0.116 |
|
| 2005 |
Flaherty L, Herron B, Symula D. Genomics of the future: identification of quantitative trait loci in the mouse. Genome Research. 15: 1741-5. PMID 16339372 DOI: 10.1101/gr.3841405 |
0.115 |
|
| 2004 |
Bolivar VJ, Flaherty L. Genetic control of novel food preference in mice. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 15: 193-8. PMID 15014968 DOI: 10.1007/s00335-003-2307-7 |
0.115 |
|
| 2002 |
Williams RW, Dubnau J, Enoch MA, Flaherty L, Sluyter F, Gannon KS, Maxson SC, Riedl CA, Williams KD, Holmes A, Bolivar VJ, Crusio WE. Hot topics in behavioral and neural genetics. Genes, Brain, and Behavior. 1: 117-30. PMID 12884982 DOI: 10.1034/j.1601-183X.2002.10207.x |
0.115 |
|
| 2002 |
Cook MN, Crounse M, Flaherty L. Anxiety in the elevated zero-maze is augmented in mice after repeated daily exposure. Behavior Genetics. 32: 113-8. PMID 12036108 DOI: 10.1023/A:1015249706579 |
0.113 |
|
| 1982 |
Flaherty L, Karl M, Reinisch CL. Syngeneic tumor immunizations produce Qa antibodies. Discovery of a new Qa antigen, Qa-6. Immunogenetics. 16: 329-37. PMID 7173999 DOI: 10.1007/BF00372304 |
0.111 |
|
| 1997 |
Baldocchi RA, Flaherty L. Isolation of genomic fragments from polymorphic regions by representational difference analysis. Methods (San Diego, Calif.). 13: 337-46. PMID 9480780 DOI: 10.1006/meth.1997.0542 |
0.109 |
|
| 1998 |
Jiang H, Kashleva H, Xu LX, Forman J, Flaherty L, Pernis B, Braunstein NS, Chess L. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proceedings of the National Academy of Sciences of the United States of America. 95: 4533-7. PMID 9539772 DOI: 10.1073/pnas.95.8.4533 |
0.107 |
|
| 1992 |
Flaherty L, Messer A, Russell LB, Rinchik EM. Chlorambucil-induced mutations in mice recovered in homozygotes. Proceedings of the National Academy of Sciences of the United States of America. 89: 2859-63. PMID 1557392 |
0.107 |
|
| 2014 |
Carson WE, Unger JM, Sosman JA, Flaherty LE, Tuthill RJ, Porter MJ, Thompson JA, Kempf RA, Othus M, Ribas A, Sondak VK. Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survival. Cancer Immunology Research. 2: 981-7. PMID 24994597 DOI: 10.1158/2326-6066.Cir-14-0052 |
0.107 |
|
| 1997 |
Royaux I, Bernier B, Montgomery JC, Flaherty L, Goffinet AM. Reln(rl-Alb2), an allele of reeler isolated from a chlorambucil screen, is due to an IAP insertion with exon skipping. Genomics. 42: 479-82. PMID 9205121 DOI: 10.1006/geno.1997.4772 |
0.101 |
|
| 1990 |
Chabot GG, Flaherty LE, Valdivieso M, Baker LH. Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients. Cancer Chemotherapy and Pharmacology. 27: 157-60. PMID 2249333 DOI: 10.1007/BF00689102 |
0.101 |
|
| 1993 |
Wade N, Flaherty L. DNA sequence analysis and polymorphism of the mouse CD4 gene. Immunogenetics. 38: 384. PMID 8344730 DOI: 10.1007/BF00210487 |
0.097 |
|
| 1987 |
Chapes SK, O'Neill AE, Flaherty L, Gooding LR. Macrophage-resistant murine simian virus 40 tumors express a retroviral type-specific gp70. Journal of Virology. 61: 928-32. PMID 3027416 |
0.096 |
|
| 2001 |
Bihl F, Larivière L, Qureshi ST, Flaherty L, Malo D. LPS-hyporesponsiveness of mnd mice is associated with a mutation in Toll-like receptor 4. Genes and Immunity. 2: 56-9. PMID 11294571 DOI: 10.1038/sj.gene.6363732 |
0.092 |
|
| 1986 |
Hoxie JA, Flaherty LE, Haggarty BS, Rackowski JL. Infection of T4 lymphocytes by HTLV-III does not require expression of the OKT4 epitope. Journal of Immunology (Baltimore, Md. : 1950). 136: 361-3. PMID 2416802 |
0.09 |
|
| 1995 |
Jiang H, Ware R, Stall A, Flaherty L, Chess L, Pernis B. Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule. Immunity. 2: 185-94. PMID 7895175 DOI: 10.1016/S1074-7613(95)80079-4 |
0.086 |
|
| 1989 |
Flaherty L. The combination of recombinant interleukin-2 and dacarbazine (DTIC) in metastatic malignant melanoma Cancer Treatment Reviews. 16: 65-66. |
0.085 |
|
| 1998 |
Flaherty L, Herron B. The new kid on the block--a whole genome mouse radiation hybrid panel. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 9: 417-8. PMID 9585426 DOI: 10.1007/s003359900788 |
0.084 |
|
| 2010 |
Lee RY, Flaherty L, Khushalani NI, Kanehira K, Nwogu C, Yendamuri S, Nava HR, Yang GY. Aorto-esophageal fistula: a rare fatal case caused by esophageal malignancy. Journal of Gastrointestinal Oncology. 1: 64-5. PMID 22811806 DOI: 10.3978/J.Issn.2078-6891.2010.006 |
0.083 |
|
| 2010 |
Flaherty L, Quiring D, Kershaw JA. Post-gall induction performance of Adelges Abietis (L.) (Homoptera: Adelgidae) is influenced by clone, shoot length, and density of colonising gallicolae Ecological Entomology. 35: 9-15. DOI: 10.1111/J.1365-2311.2009.01135.X |
0.082 |
|
| 1998 |
Flaherty L. Generation, identification, and recovery of mouse mutations. Methods (San Diego, Calif.). 14: 107-18. PMID 9571070 DOI: 10.1006/meth.1997.0571 |
0.081 |
|
| 1998 |
Flaherty L, Moloney J, Watson N, Robson L, Bousfield L, Smith A. A case of monosomy 21 found to be an unbalanced de novo t(5p;21q) by fluorescence in situ hybridization. Journal of Intellectual Disability Research : Jidr. 42: 254-8. PMID 9678410 |
0.08 |
|
| 1998 |
Whitehead RP, Unger JM, Goodwin JW, Walker MJ, Thompson JA, Flaherty LE, Sondak VK. Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: a Southwest Oncology Group study. Journal of Immunotherapy (Hagerstown, Md. : 1997). 21: 440-6. PMID 9807739 |
0.079 |
|
| 1981 |
Rosenson RS, Flaherty L, Reinisch CL. Induction of surface Qa2 on lymphoid cells. Journal of Immunology (Baltimore, Md. : 1950). 126: 2253-7. PMID 7229374 |
0.077 |
|
| 1993 |
Sharar SR, Sasaki SS, Flaherty LC, Paulson JC, Harlan JM, Winn RK. P-selectin blockade does not impair leukocyte host defense against bacterial peritonitis and soft tissue infection in rabbits. Journal of Immunology (Baltimore, Md. : 1950). 151: 4982-8. PMID 7691961 |
0.076 |
|
| 2002 |
Whitehead RP, Unger JM, Flaherty LE, Kraut EH, Mills GM, Klein CE, Chapman RA, Doolittle GC, Hammond N, Sondak VK. A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group study. Investigational New Drugs. 20: 105-11. PMID 12003185 DOI: 10.1023/A:1014484821460 |
0.076 |
|
| 1999 |
Flaherty L, Smith A, Castaldi P. Second case of t(6;7)(p21;q36) in acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 112: 188-9. PMID 10686953 DOI: 10.1016/S0165-4608(98)00272-6 |
0.074 |
|
| 2001 |
Whitehead RP, Unger JM, Flaherty LE, Eckardt JR, Taylor SA, Didolkar MS, Samlowski W, Sondak VK. Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy. A Southwest Oncology Group study. Investigational New Drugs. 19: 239-43. PMID 11561681 DOI: 10.1023/A:1010624702340 |
0.074 |
|
| 2008 |
Sosman JA, Carrillo C, Urba WJ, Flaherty L, Atkins MB, Clark JI, Dutcher J, Margolin KA, Mier J, Gollob J, Kirkwood JM, Panka DJ, Crosby NA, O'Boyle K, LaFleur B, et al. Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2292-8. PMID 18467720 DOI: 10.1200/JCO.2007.13.3165 |
0.072 |
|
| 2012 |
Margolin KA, Moon J, Flaherty LE, Lao CD, Akerley WL, Othus M, Sosman JA, Kirkwood JM, Sondak VK. Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1129-37. PMID 22228638 DOI: 10.1158/1078-0432.Ccr-11-2488 |
0.072 |
|
| 2002 |
LoRusso PM, Prakash S, Wozniak A, Flaherty L, Zalupski M, Shields A, Sands H, Parchment R, Jasti B. Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU). Investigational New Drugs. 20: 63-71. PMID 12003195 DOI: 10.1023/A:1014430216434 |
0.07 |
|
| 1990 |
Redman BG, Flaherty L, Chou TH, al-Katib A, Kraut M, Martino S, Chen B, Kaplan J, Valdivieso M. A phase I trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 8: 1269-76. PMID 2113571 DOI: 10.1200/Jco.1990.8.7.1269 |
0.069 |
|
| 1975 |
Mathieson BJ, Flaherty L, Bennett D, Boyse EA. Differences in the rejection of trunk skin and tail skin allografts involving weak histocompatibility loci. Transplantation. 19: 525-7. PMID 49110 |
0.068 |
|
| 2013 |
Flaherty L, Quiring D, Pureswaran D, Sweeney J. Evaluating seasonal variation in bottom-up and top-down forces and their impact on an exotic wood borer, Tetropium fuscum (Coleoptera: Cerambycidae). Environmental Entomology. 42: 957-66. PMID 24073794 DOI: 10.1603/En13043 |
0.067 |
|
| 2011 |
Flaherty L, Sweeney JD, Pureswaran D, Quiring DT. Influence of host tree condition on the performance of Tetropium fuscum (Coleoptera: Cerambycidae). Environmental Entomology. 40: 1200-9. PMID 22251731 DOI: 10.1603/EN11114 |
0.066 |
|
| 2008 |
Sondak VK, Flaherty LE. Adjuvant therapy of melanoma: is pegylated interferon alfa-2b what we've been waiting for? Lancet. 372: 89-90. PMID 18620932 DOI: 10.1016/S0140-6736(08)61011-9 |
0.065 |
|
| 2014 |
Flaherty L, Hamid O, Linette G, Schuchter L, Hallmeyer S, Gonzalez R, Cowey CL, Pavlick A, Kudrik F, Curti B, Lawson D, Chapman PB, Margolin K, Ribas A, McDermott D, et al. A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States. Cancer Journal (Sudbury, Mass.). 20: 18-24. PMID 24445759 DOI: 10.1097/PPO.0000000000000024 |
0.064 |
|
| 1995 |
Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty LE, Richards JM, Bartolucci AA. A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma. Cancer. 75: 34-42. PMID 7804974 DOI: 10.1002/1097-0142(19950101)75:1<34::Aid-Cncr2820750108>3.0.Co;2-0 |
0.063 |
|
| 2007 |
Hutchins LF, Moon J, Clark JI, Thompson JA, Lange MK, Flaherty LE, Sondak VK. Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026. Cancer. 110: 2269-75. PMID 17932881 DOI: 10.1002/cncr.23035 |
0.062 |
|
| 2000 |
Kirkwood JM, Ibrahim JG, Sondak VK, Richards J, Flaherty LE, Ernstoff MS, Smith TJ, Rao U, Steele M, Blum RH. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 2444-58. PMID 10856105 DOI: 10.1200/Jco.2000.18.12.2444 |
0.061 |
|
| 1998 |
Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Bartolucci AA, Rosen L. Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial. Journal of the American College of Surgeons. 187: 69-77; discussion 77. PMID 9660028 DOI: 10.1016/S1072-7515(98)00097-0 |
0.059 |
|
| 2014 |
Ribas A, Gonzalez R, Pavlick A, Hamid O, Gajewski TF, Daud A, Flaherty L, Logan T, Chmielowski B, Lewis K, Kee D, Boasberg P, Yin M, Chan I, Musib L, et al. Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study. The Lancet. Oncology. 15: 954-65. PMID 25037139 DOI: 10.1016/S1470-2045(14)70301-8 |
0.059 |
|
| 2010 |
Clark JI, Moon J, Hutchins LF, Sosman JA, Kast WM, Da Silva DM, Liu PY, Thompson JA, Flaherty LE, Sondak VK. Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508. Cancer. 116: 424-31. PMID 19918923 DOI: 10.1002/Cncr.24739 |
0.059 |
|
| 2013 |
Flaherty L, Quiring D, Pureswaran D, Sweeney J. Preference of an exotic wood borer for stressed trees is more attributable to pre-alighting than post-alighting behaviour Ecological Entomology. 38: 546-552. DOI: 10.1111/Een.12045 |
0.058 |
|
| 2010 |
Samlowski WE, Moon J, Tuthill RJ, Heinrich MC, Balzer-Haas NS, Merl SA, DeConti RC, Thompson JA, Witter MT, Flaherty LE, Sondak VK. A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331). American Journal of Clinical Oncology. 33: 495-9. PMID 20019577 DOI: 10.1200/Jco.2009.27.15_Suppl.9056 |
0.058 |
|
| 2014 |
Flaherty LE, Othus M, Atkins MB, Tuthill RJ, Thompson JA, Vetto JT, Haluska FG, Pappo AS, Sosman JA, Redman BG, Moon J, Ribas A, Kirkwood JM, Sondak VK. Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma--an intergroup study of cancer and leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3771-8. PMID 25332243 DOI: 10.1200/Jco.2013.53.1590 |
0.057 |
|
| 1993 |
Flaherty LE, Robinson W, Redman BG, Gonzalez R, Martino S, Kraut M, Valdivieso M, Rudolph AR. A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanoma. Cancer. 71: 3520-5. PMID 8490900 DOI: 10.1002/1097-0142(19930601)71:11<3520::AID-CNCR2820711110>3.0.CO;2-A |
0.057 |
|
| 2005 |
McDermott DF, Regan MM, Clark JI, Flaherty LE, Weiss GR, Logan TF, Kirkwood JM, Gordon MS, Sosman JA, Ernstoff MS, Tretter CP, Urba WJ, Smith JW, Margolin KA, Mier JW, et al. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 133-41. PMID 15625368 DOI: 10.1200/JCO.2005.03.206 |
0.057 |
|
| 1998 |
Flaherty L, Jarvis A, Harris M, Tyrrell V, Smith A. A case of chronic myelomonocytic leukemia with isochromosome 14q. Cancer Genetics and Cytogenetics. 101: 134-7. PMID 9494615 DOI: 10.1016/S0165-4608(97)00254-9 |
0.056 |
|
| 2001 |
Flaherty LE, Atkins M, Sosman J, Weiss G, Clark JI, Margolin K, Dutcher J, Gordon MS, Lotze M, Mier J, Sorokin P, Fisher RI, Appel C, Du W. Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 3194-202. PMID 11432886 DOI: 10.1200/JCO.2001.19.13.3194 |
0.056 |
|
| 2007 |
Vaishampayan UN, Heilbrun LK, Marsack C, Smith DW, Flaherty LE. Phase II trial of pegylated interferon and thalidomide in malignant metastatic melanoma. Anti-Cancer Drugs. 18: 1221-6. PMID 17893524 DOI: 10.1097/CAD.0b013e3282eea391 |
0.055 |
|
| 1990 |
Flaherty LE, Redman BG, Chabot GG, Martino S, Gualdoni SM, Heilbrun LK, Valdivieso M, Bradley EC. A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma. Cancer. 65: 2471-7. PMID 2337862 |
0.055 |
|
| 2014 |
Weise AM, Flaherty LE. New options for the adjuvant treatment of cutaneous melanoma? Current Oncology Reports. 16: 409. PMID 25286906 DOI: 10.1007/s11912-014-0409-x |
0.054 |
|
| 1994 |
Redman BG, Abubakr Y, Chou T, Esper P, Flaherty LE. Phase II trial of recombinant interleukin-1 beta in patients with metastatic renal cell carcinoma. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 16: 211-5. PMID 7834120 |
0.054 |
|
| 1994 |
Momin FA, Zalupski M, Heilbrun LK, Flaherty L, Fyfe G, Baker LH, Redman BG. Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcoma. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 16: 224-8. PMID 7834122 DOI: 10.1097/00002371-199410000-00007 |
0.054 |
|
| 2002 |
Flaherty LE, Gadgeel SM. Biochemotherapy of melanoma. Seminars in Oncology. 29: 446-55. PMID 12407509 DOI: 10.1053/sonc.2002.35239 |
0.052 |
|
| 2000 |
Philip PA, Flaherty LE. Biochemotherapy for melanoma. Current Oncology Reports. 2: 314-21. PMID 11122859 |
0.052 |
|
| 1982 |
Lynes MA, Tonkonogy S, Flaherty L. Qa-1 and Qa-2 expression on CFU-s. Journal of Immunology (Baltimore, Md. : 1950). 129: 928-30. PMID 7108211 |
0.052 |
|
| 2010 |
Croghan GA, Suman VJ, Maples WJ, Albertini M, Linette G, Flaherty L, Eckardt J, Ma C, Markovic SN, Erlichman C. A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: a phase 2 consortium study. Cancer. 116: 3463-8. PMID 20564112 DOI: 10.1002/cncr.25191 |
0.051 |
|
| 2010 |
Rhainds M, Heard SB, Sweeney JD, Silk P, Flaherty L. Phenology and spatial distribution of native and exotic Tetropium longhorned beetles (Coleoptera: Cerambycidae). Environmental Entomology. 39: 1794-800. PMID 22182544 DOI: 10.1603/EN10164 |
0.051 |
|
| 2008 |
Atkins MB, Hsu J, Lee S, Cohen GI, Flaherty LE, Sosman JA, Sondak VK, Kirkwood JM. Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5748-54. PMID 19001327 DOI: 10.1200/JCO.2008.17.5448 |
0.05 |
|
| 2003 |
Hussain M, Vaishampayan U, Heilbrun LK, Jain V, LoRusso PM, Ivy P, Flaherty L. A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer. Investigational New Drugs. 21: 465-71. PMID 14586215 DOI: 10.1023/A:1026259503954 |
0.047 |
|
| 1996 |
Flaherty LE, Liu PY, Mitchell MS, Fletcher WS, Walker MJ, Goodwin JW, Stephens RL, Sondak VK. The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921). American Journal of Clinical Oncology. 19: 108-13. PMID 8610631 |
0.046 |
|
| 1998 |
Redman BG, Hillman GG, Flaherty L, Forman J, Dezso B, Haas GP. Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 4: 283-6. PMID 9516912 |
0.046 |
|
| 2007 |
Vaishampayan UN, Heilbrun LK, Shields AF, Lawhorn-Crews J, Baranowski K, Smith D, Flaherty LE. Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma. Investigational New Drugs. 25: 69-75. PMID 16937078 DOI: 10.1007/S10637-006-9005-8 |
0.045 |
|
| 1998 |
Margolin KA, Liu PY, Flaherty LE, Sosman JA, Walker MJ, Smith JW, Fletcher WS, Weiss GR, Unger JM, Sondak VK. Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 664-9. PMID 9469356 |
0.045 |
|
| 1998 |
Flaherty LE, Unger JM, Liu PY, Mertens WC, Sondak VK. Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials. American Journal of Clinical Oncology. 21: 568-72. PMID 9856657 |
0.045 |
|
| 2015 |
Budd GT, Barlow WE, Moore HC, Hobday TJ, Stewart JA, Isaacs C, Salim M, Cho JK, Rinn KJ, Albain KS, Chew HK, Burton GV, Moore TD, Srkalovic G, McGregor BA, ... Flaherty LE, et al. SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 58-64. PMID 25422488 DOI: 10.1200/Jco.2014.56.3296 |
0.044 |
|
| 1990 |
Birchfield GR, Ward JH, Redman BG, Flaherty L, Samlowski WE. Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanoma. The Western Journal of Medicine. 152: 714-6. PMID 2353479 |
0.044 |
|
| 2013 |
Flaherty KT, Lee SJ, Zhao F, Schuchter LM, Flaherty L, Kefford R, Atkins MB, Leming P, Kirkwood JM. Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 373-9. PMID 23248256 DOI: 10.1200/JCO.2012.42.1529 |
0.044 |
|
| 2002 |
Sondak VK, Liu PY, Tuthill RJ, Kempf RA, Unger JM, Sosman JA, Thompson JA, Weiss GR, Redman BG, Jakowatz JG, Noyes RD, Flaherty LE. Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2058-66. PMID 11956266 DOI: 10.1200/JCO.2002.08.071 |
0.044 |
|
| 2003 |
Clark JI, Atkins MB, Urba WJ, Creech S, Figlin RA, Dutcher JP, Flaherty L, Sosman JA, Logan TF, White R, Weiss GR, Redman BG, Tretter CP, McDermott D, Smith JW, et al. Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 3133-40. PMID 12810695 DOI: 10.1200/JCO.2003.02.014 |
0.043 |
|
| 1974 |
Lynch JJ, Flaherty L, Emrich C, Mills ME, Katcher A. Effects of human contact on the heart activity of curarized patients in a shock-trauma unit. American Heart Journal. 88: 160-9. PMID 4841217 DOI: 10.1016/0002-8703(74)90005-2 |
0.043 |
|
| 1992 |
Flaherty LE, Liu PY, Fletcher WS, Goodwin JW, Balcerzak SP, Daniels D, Stephens RL, Sondak VK. Dacarbazine and outpatient interleukin-2 in treatment of metastatic malignant melanoma: phase II Southwest Oncology Group trial. Journal of the National Cancer Institute. 84: 893-4. PMID 1593656 |
0.043 |
|
| 1997 |
Flaherty LE, Liu PY, Unger J, Sondak VK. Comparison of patient characteristics and outcome between a single-institution phase II trial and a cooperative-group phase II trial with identical eligibility in metastatic melanoma. American Journal of Clinical Oncology. 20: 600-4. PMID 9391549 DOI: 10.1097/00000421-199712000-00014 |
0.042 |
|
| 2008 |
Flaherty L, Quiring D. Plant module size and dose of gall induction stimulus influence gall induction and galler performance Oikos. 117: 1601-1608. DOI: 10.1111/J.1600-0706.2008.16555.X |
0.042 |
|
| 1998 |
Smith DC, Redman BG, Flaherty LE, Li L, Strawderman M, Pienta KJ. A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer. Urology. 52: 257-60. PMID 9697791 DOI: 10.1016/S0090-4295(98)00173-3 |
0.042 |
|
| 1990 |
Flaherty LE, Schwert R, Redman BG. Case report: development of Hodgkin's disease in patient receiving long-term administration of dacarbazine and interleukin-2 for metastatic melanoma. Journal of the National Cancer Institute. 82: 1360. PMID 2380992 DOI: 10.1093/jnci/82.16.1360 |
0.042 |
|
| 1995 |
Sosman JA, Flaherty LE, Liu PY, Fletcher W, Thompson JA, Hantel A, Sondak V. A phase II trial of piroxantrone in disseminated malignant melanoma. A Southwest Oncology Group study. Investigational New Drugs. 13: 83-7. PMID 7499114 DOI: 10.1007/BF02614226 |
0.041 |
|
| 2015 |
Lee SM, Moon J, Redman BG, Chidiac T, Flaherty LE, Zha Y, Othus M, Ribas A, Sondak VK, Gajewski TF, Margolin KA. Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933. Cancer. 121: 432-40. PMID 25250858 DOI: 10.1002/Cncr.29055 |
0.041 |
|
| 2002 |
Tuthill RJ, Unger JM, Liu PY, Flaherty LE, Sondak VK. Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model. American Journal of Clinical Pathology. 118: 504-11. PMID 12375635 DOI: 10.1309/WBF7-N8KH-71KT-RVQ9 |
0.041 |
|
| 1992 |
Redman BG, Flaherty L, Chou TH, Kraut M, Martino S, Simon M, Valdivieso M, Groves E. Phase I trial of recombinant macrophage colony-stimulating factor by rapid intravenous infusion in patients with cancer. Journal of Immunotherapy : Official Journal of the Society For Biological Therapy. 12: 50-4. PMID 1637782 DOI: 10.1097/00002371-199207000-00006 |
0.041 |
|
| 2001 |
Vaishampayan U, Flaherty L, Du W, Hussain M. Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acid in advanced renal cell carcinoma. Cancer. 92: 519-23. PMID 11505395 DOI: 10.1002/1097-0142(20010801)92:3<519::AID-CNCR1350>3.0.CO;2-# |
0.04 |
|
| 2010 |
May KS, Yang GY, Khushalani NI, Chandrasekhar R, Wilding GE, Flaherty L, Malhotra HK, Russo RC, Warner JC, Yap JC, Iyer RV, Nwogu CE, Yendamuri SS, Gibbs JF, Nava HR, et al. Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies. Journal of Gastrointestinal Oncology. 1: 7-15. PMID 22811800 DOI: 10.3978/J.Issn.2078-6891.2010.001 |
0.04 |
|
| 1997 |
Philip PA, Flaherty L. Treatment of malignant melanoma with interleukin-2. Seminars in Oncology. 24: S32-8. PMID 9122732 |
0.04 |
|
| 2011 |
Livingston RB, Barlow WE, Kash JJ, Albain KS, Gralow JR, Lew DL, Flaherty LE, Royce ME, Hortobagyi GN. SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer. Breast Cancer Research and Treatment. 130: 123-31. PMID 21826527 DOI: 10.1007/S10549-011-1698-5 |
0.04 |
|
| 2002 |
Rao UN, Ibrahim J, Flaherty LE, Richards J, Kirkwood JM. Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of Eastern Cooperative Oncology Group Trial E1690. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2053-7. PMID 11956265 |
0.04 |
|
| 2005 |
Atallah E, Flaherty L. Treatment of metastatic malignant melanoma. Current Treatment Options in Oncology. 6: 185-93. PMID 15869730 |
0.039 |
|
| 1995 |
Redman BG, Chou TH, Zalupski M, Uberti J, Flaherty L, Dan M, Sensenbrenner L. Phase I trial of sequential cyclophosphamide, cyclosporin A, and interferon-alpha in patients with cancer: attempt to induce autologous graft-versus-host reaction to elicit an antitumor response. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 18: 115-8. PMID 8574466 |
0.039 |
|
| 1997 |
Wallack MK, Sivanandham M, Ditaranto K, Shaw P, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Rosen L, Bartolucci AA. Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial. Annals of Surgery. 226: 198-206. PMID 9296514 DOI: 10.1097/00000658-199708000-00012 |
0.039 |
|
| 1991 |
Redman BG, Flaherty L, Chou TH, Nakeff A, Pillote K, Kaplan J. Sequential dacarbazine/cisplatin and interleukin-2 in metastatic melanoma: immunological effects of therapy. Journal of Immunotherapy : Official Journal of the Society For Biological Therapy. 10: 147-51. PMID 2043595 |
0.039 |
|
| 1999 |
Sondak VK, Liu PY, Flaherty LE, Fletcher WS, Periman P, Gandara DR, Taylor SA, Balcerzak SP, Meyskens FL. A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study. The Cancer Journal From Scientific American. 5: 41-7. PMID 10188060 |
0.038 |
|
| 1993 |
Langdale LA, Flaherty LC, Liggitt HD, Harlan JM, Rice CL, Winn RK. Neutrophils contribute to hepatic ischemia-reperfusion injury by a CD18-independent mechanism. Journal of Leukocyte Biology. 53: 511-7. PMID 8099114 DOI: 10.1002/Jlb.53.5.511 |
0.037 |
|
| 2010 |
May KS, Khushalani NI, Chandrasekhar R, Wilding GE, Iyer RV, Ma WW, Flaherty L, Russo RC, Fakih M, Kuvshinoff BW, Gibbs JF, Javle MM, Yang GY. Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen. International Journal of Radiation Oncology, Biology, Physics. 76: 1193-8. PMID 19540051 DOI: 10.1016/J.Ijrobp.2009.03.002 |
0.037 |
|
| 2000 |
Flaherty LE. Rationale for intergroup trial E-3695 comparing concurrent biochemotherapy with cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma. The Cancer Journal From Scientific American. 6: S15-20. PMID 10685653 |
0.036 |
|
| 1986 |
Shattil SJ, Motulsky HJ, Insel PA, Flaherty L, Brass LF. Expression of fibrinogen receptors during activation and subsequent desensitization of human platelets by epinephrine. Blood. 68: 1224-31. PMID 3779100 DOI: 10.1182/Blood.V68.6.1224.1224 |
0.036 |
|
| 2002 |
Margolin K, Atkins B, Thompson A, Ernstoff S, Weber J, Flaherty L, Clark I, Weiss G, Sosman J, II Smith W, Dutcher P, Gollob J, Longmate J, Johnson D. Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. Journal of Cancer Research and Clinical Oncology. 128: 214-8. PMID 11935312 DOI: 10.1007/s00432-002-0323-8 |
0.035 |
|
| 1998 |
Redman BG, Smith DC, Flaherty L, Du W, Hussain M. Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 1844-8. PMID 9586899 DOI: 10.1200/JCO.1998.16.5.1844 |
0.035 |
|
| 1981 |
Carrera GF, Kozin F, Flaherty L, McCarty DJ. Radiographic changes in the hands following childhood frostbite injury. Skeletal Radiology. 6: 33-7. PMID 7466414 DOI: 10.1007/BF00347344 |
0.035 |
|
| 1996 |
Foster BJ, LoRusso PM, Poplin E, Zalupski M, Valdivieso M, Wozniak A, Flaherty L, Kasunic DA, Earhart RH, Baker LH. Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks. Investigational New Drugs. 13: 321-6. PMID 8824350 DOI: 10.1007/BF00873138 |
0.035 |
|
| 1995 |
Slavik M, Liu PY, Kraut EH, Natale RB, Flaherty LE, Sondak VK. Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group study. Investigational New Drugs. 13: 143-7. PMID 8617577 |
0.034 |
|
| 1999 |
Margolin KA, Liu PY, Unger JM, Fletcher WS, Flaherty LE, Urba WJ, Hersh EM, Hutchins LE, Sosman JA, Smith JW, Weiss GR, Sondak VK. Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial. Journal of Cancer Research and Clinical Oncology. 125: 292-6. PMID 10359134 |
0.033 |
|
| 2006 |
Thatai LC, Vishnubhotla P, Biernat L, Flaherty L, LoRusso P, Simon M, Stephens D, Vereeke K, Abrams J, Bouwman D, Philip PA. A phase II study of docetaxel, doxorubicin, and infusional 5-fluorouracil in the treatment of patients with locally advanced breast cancer. American Journal of Clinical Oncology. 29: 484-9. PMID 17023784 DOI: 10.1097/01.coc.0000231439.42503.44 |
0.032 |
|
| 2013 |
Yang GY, Malik NK, Chandrasekhar R, Ma WW, Flaherty L, Iyer R, Kuvshinoff B, Gibbs J, Wilding G, Warren G, May KS. Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. Journal of Gastrointestinal Oncology. 4: 361-9. PMID 24294507 DOI: 10.3978/J.Issn.2078-6891.2013.045 |
0.032 |
|
| 1991 |
Flaherty L, Wozniak A, Redman B, Kraut M, Martino S, Heilbrun L, Valdivieso M. 5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer. Cancer. 68: 944-7. PMID 1655218 |
0.032 |
|
| 1993 |
Winn RK, Vedder NB, Mihelcic D, Flaherty LC, Langdale L, Harlan JM. The role of adhesion molecules in reperfusion injury. Agents and Actions. Supplements. 41: 113-26. PMID 8317335 |
0.032 |
|
| 1996 |
Katato K, Flaherty L, Varterasian M. Secondary acute myelogenous leukemia following treatment with oral etoposide. American Journal of Hematology. 53: 54-5. PMID 8813107 DOI: 10.1002/(SICI)1096-8652(199609)53:1<54::AID-AJH17>3.0.CO;2-3 |
0.031 |
|
| 1997 |
Pienta KJ, Esper PS, Zwas F, Krzeminski R, Flaherty LE. Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostate. American Journal of Clinical Oncology. 20: 36-9. PMID 9020285 |
0.031 |
|
| 2005 |
Flaherty L. Developmental and clinical studies: Editor's introduction Adolescent Psychiatry. 29: vii-ix. |
0.03 |
|
| 1998 |
Flaherty L, Snyder JA. Department of Health and Human Services: Centers for Disease Control and Prevention. Human rabies - Recent case reports and availability of new vaccine for human use Journal of Emergency Nursing. 24: 337-340. |
0.03 |
|
| 2005 |
Flaherty LM, Jordan JM. Sorbent performance study for crude and refined petroleum products 2005 International Oil Spill Conference, Iosc 2005. 7852. |
0.03 |
|
| 2012 |
Gartner EM, Silverman P, Simon M, Flaherty L, Abrams J, Ivy P, Lorusso PM. A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer. Breast Cancer Research and Treatment. 131: 933-7. PMID 22083229 DOI: 10.1007/s10549-011-1866-7 |
0.029 |
|
| 1990 |
Martino S, Samal BA, Redman B, Flaherty L, Kraut M, Simon M, Valdivieso M. Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer. Breast Cancer Research and Treatment. 17: 139-43. PMID 2096991 DOI: 10.1007/BF01806294 |
0.029 |
|
| 2011 |
Sosman JA, Moon J, Tuthill RJ, Warneke JA, Vetto JT, Redman BG, Liu PY, Unger JM, Flaherty LE, Sondak VK. A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430. Cancer. 117: 4740-06. PMID 21455999 DOI: 10.1002/cncr.26111 |
0.028 |
|
| 2001 |
Unger JM, Flaherty LE, Liu PY, Albain KS, Sondak VK. Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials. Cancer. 91: 1148-55. PMID 11267960 DOI: 10.1002/1097-0142(20010315)91:6<1148::AID-CNCR1111>3.0.CO;2-# |
0.028 |
|
| 1996 |
Pienta KJ, Redman BG, Esper PS, Flaherty LE. A phase II evaluation of oral tamoxifen and intermittent intravenous vinblastine in hormone-refractory adenocarcinoma of the prostate. American Journal of Clinical Oncology. 19: 500-3. PMID 8823479 |
0.028 |
|
| 2012 |
Flaherty LT. What's Old is New: Motivational Interviewing for Adolescents Clinical Handbook of Adolescent Addiction. 321-326. DOI: 10.1002/9781118340851.ch33 |
0.028 |
|
| 1994 |
Pienta KJ, Redman B, Hussain M, Cummings G, Esper PS, Appel C, Flaherty LE. Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 12: 2005-12. PMID 7523606 |
0.028 |
|
| 2002 |
Kirkwood JM, Ibrahim J, Sondak VK, Ernstoff MS, Flaherty L, Haluska FJ, Lens MB, Dawes M. Use and abuse of statistics in evidence-based medicine [3] (multiple letters) Journal of Clinical Oncology. 20: 4122-4124. DOI: 10.1200/JCO.2002.99.132 |
0.026 |
|
| 1991 |
Flaherty L, Colomy A. Look at the hidden costs of automation National Electronic Packaging and Production Conference-Proceedings of the Technical Program (West and East). 2: 1032-1039. |
0.026 |
|
| 1981 |
Taylor P, Hallett M, Flaherty L. Treatment of osteoarthritis of the knee with transcutaneous electrical nerve stimulation. Pain. 11: 233-40. PMID 7033891 DOI: 10.1016/0304-3959(81)90008-7 |
0.025 |
|
| 2002 |
Kirkwood JM, Ibrahim J, Sondak VK, Ernstoff MS, Flaherty L, Haluska FJ. Use and abuse of statistics in evidence-based medicine. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 4122-3; author reply. PMID 12351612 |
0.024 |
|
| 2004 |
Flaherty L. Editor's introduction Adolescent Psychiatry. 28: vii-x. |
0.024 |
|
| 2000 |
Sondak VK, Flaherty LE. Adjuvant high-dose interferon revisited. Cancer Journal (Sudbury, Mass.). 6: 132-4. PMID 10882326 |
0.024 |
|
| 2012 |
Malik NK, May KS, Chandrasekhar R, Wee W, Flaherty L, Iyer R, Gibbs J, Kuvshinoff B, Wilding G, Warren G, Yang GY. Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience. Journal of Gastrointestinal Oncology. 3: 326-34. PMID 23205309 DOI: 10.3978/J.Issn.2078-6891.2012.029 |
0.023 |
|
| 1992 |
Redman BG, Flaherty L, Martino S, Kraut M, Wisniewski C, Valdivieso M, Bander JJ. Effect of calcium replacement on the hemodynamic changes associated with high dose interleukin-2 therapy. American Journal of Clinical Oncology. 15: 340-3. PMID 1514532 |
0.023 |
|
| 1992 |
Goel M, Flaherty L, Lavine S, Redman BG. Reversible cardiomyopathy after high-dose interleukin-2 therapy. Journal of Immunotherapy : Official Journal of the Society For Biological Therapy. 11: 225-9. PMID 1515427 |
0.022 |
|
| 1999 |
Flaherty LT, Weist MD. School-based mental health services: The Baltimore models Psychology in the Schools. 36: 379-389. DOI: 10.1002/(Sici)1520-6807(199909)36:5<379::Aid-Pits2>3.0.Co;2-D |
0.021 |
|
| 2000 |
Trivedi C, Redman B, Flaherty LE, Kucuk O, Du W, Heilbrun LK, Hussain M. Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma. Cancer. 89: 431-6. PMID 10918176 DOI: 10.1002/1097-0142(20000715)89:2<431::AID-CNCR31>3.0.CO;2-B |
0.021 |
|
| 2013 |
Horner K, Ludman EJ, McCorkle R, Canfield E, Flaherty L, Min J, Miyoshi J, Lapham B, Bowles EJ, Wagner EH. An oncology nurse navigator program designed to eliminate gaps in early cancer care. Clinical Journal of Oncology Nursing. 17: 43-8. PMID 23372095 DOI: 10.1188/13.Cjon.43-48 |
0.02 |
|
| 2005 |
Daley ML, Becker DF, Flaherty LT, Harper G, King RA, Lester P, Milosavljevic N, Onesti SJ, Rappaport N, Schwab-Stone M. Case study: the internet as a developmental tool in an adolescent boy with psychosis. Journal of the American Academy of Child and Adolescent Psychiatry. 44: 187-90. PMID 15689732 DOI: 10.1097/00004583-200502000-00011 |
0.02 |
|
| 2011 |
Sondak VK, Flaherty LE. Targeted therapies: Improved outcomes for patients with metastatic melanoma. Nature Reviews. Clinical Oncology. 8: 513-5. PMID 21788973 DOI: 10.1038/nrclinonc.2011.119 |
0.02 |
|
| 1984 |
Flaherty LM, Nielsen SE. COMMUNITY RELATIONS IN SUPERFUND REMOVAL OPERATIONS . 397-402. |
0.02 |
|
| 2011 |
Tabuchi K, Quiring DT, Flaherty LE, Pinault LL, Ozaki K. Bottom-up trophic cascades caused by moose browsing on a natural enemy of a galling insect on balsam fir Basic and Applied Ecology. 12: 523-531. DOI: 10.1016/j.baae.2011.06.007 |
0.02 |
|
| 2012 |
Coakley C, Bolton P, Flaherty L, Kopeski LM, Slifka K, Sutherland MA. The incidence of metabolic risk factors in an inpatient psychiatric setting. Journal of Psychosocial Nursing and Mental Health Services. 50: 24-30. PMID 22329619 DOI: 10.3928/02793695-20120207-01 |
0.019 |
|
| 2004 |
DeMarco R, Flaherty L, Glod C, Merrill N, Terk K, Plasse M. Staff & client perceptions of unit quality: a pilot study. Journal of Psychosocial Nursing and Mental Health Services. 42: 36-43. PMID 15182048 |
0.019 |
|
| 2013 |
Harper G, Becker DF, Copans SA, Flaherty LT, Ghalib K, Gharib K, Krasner AJ, Kwok S, Onesti SJ, Wittenberg J. Being with the patient: the use of "clinical evidence," reconsidered. The Journal of Nervous and Mental Disease. 201: 813-7. PMID 23995038 DOI: 10.1097/NMD.0b013e3182a2142f |
0.019 |
|
| 2003 |
Flaherty L. From the feds: Research, programs and products Journal of Emergency Nursing. 29: 347-348. DOI: 10.1067/men.2003.91 |
0.018 |
|
| 2003 |
Flaherty L. From the feds: Research, programs, and products Journal of Emergency Nursing. 29: 264. DOI: 10.1067/men.2003.56 |
0.018 |
|
| 1992 |
Poplin EA, Corbett T, Flaherty L, Tarasoff P, Redman BG, Valdivieso M, Baker L. Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study. Investigational New Drugs. 10: 165-70. PMID 1428726 DOI: 10.1007/BF00877241 |
0.018 |
|
| 2004 |
Simon MS, Du W, Flaherty L, Philip PA, Lorusso P, Miree C, Smith D, Brown DR. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 2046-52. PMID 15082724 DOI: 10.1200/JCO.2004.03.005 |
0.018 |
|
| 1991 |
Talbott JA, Bray JD, Flaherty L, Robinowitz C, Taintor Z. State-university collaboration in psychiatry: the Pew Memorial Trust Program. Community Mental Health Journal. 27: 425-39. PMID 1773600 DOI: 10.1007/BF00752666 |
0.018 |
|
| 2001 |
Weist MD, Lowie JA, Flaherty LT, Pruitt D. Collaboration among the education, mental health, and public health systems to promote youth mental health. Psychiatric Services (Washington, D.C.). 52: 1348-51. PMID 11585951 DOI: 10.1176/Appi.Ps.52.10.1348 |
0.018 |
|
| 1996 |
Weist MD, Paskewitz DA, Warner BS, Flaherty LT. Treatment outcome of school-based mental health services for urban teenagers. Community Mental Health Journal. 32: 149-57. PMID 8777871 DOI: 10.1007/Bf02249752 |
0.017 |
|
| 1969 |
DeVito RA, Flaherty LA, Mozdzierz GJ. New dimensions in the treatment of alcoholism. Imj. Illinois Medical Journal. 135: 389-92. PMID 4388489 |
0.017 |
|
| 2013 |
Platz TA, Nurkin SJ, Fong MK, Groman A, Flaherty L, Malhotra U, Levea CM, Yendamuri S, Warren GW, Nava HR, May KS. Neoadjuvant chemoradiotherapy for esophageal/gastroesophageal carcinoma. Journal of Gastrointestinal Oncology. 4: 137-43. PMID 23730509 DOI: 10.3978/j.issn.2078-6891.2013.007 |
0.017 |
|
| 2001 |
Prakash S, Foster BJ, Meyer M, Wozniak A, Heilbrun LK, Flaherty L, Zalupski M, Radulovic L, Valdivieso M, LoRusso PM. Chronic oral administration of CI-994: a phase 1 study. Investigational New Drugs. 19: 1-11. PMID 11291827 |
0.017 |
|
| 1998 |
Flaherty LT, Garrison EG, Waxman R, Uris PF, Keys SG, Glass-Siegel M, Weist MD. Optimizing the roles of school mental health professionals. The Journal of School Health. 68: 420-4. PMID 9919497 DOI: 10.1111/J.1746-1561.1998.Tb06321.X |
0.016 |
|
| 2003 |
Becker DF, Daley M, Green MR, Hendren RL, Flaherty LT, Gadpaille WJ, Harper G, King RA, Lester P, Onesti SJ, Schwab-Stone M, Wong SW. Trauma and Adolescence II: The Impact of Trauma Adolescent Psychiatry. 27: 165-200. |
0.015 |
|
| 1994 |
Hussain MH, Pienta KJ, Redman BG, Cummings GD, Flaherty LE. Oral etoposide in the treatment of hormone-refractory prostate cancer. Cancer. 74: 100-3. PMID 8004566 |
0.015 |
|
| 2005 |
Payne JR, Phillips CR, Floyd M, Longmire G, Fernandez J, Flaherty LM. Estimating dispersant effectiveness under low temperature-low salinity conditions 2005 International Oil Spill Conference, Iosc 2005. 2635. |
0.015 |
|
| 2001 |
Flaherty L. Lyme disease in the United States, 1999 Journal of Emergency Nursing. 27: 574-575. DOI: 10.1067/men.2001.117210 |
0.015 |
|
| 2012 |
Flaherty L, Régnière J, Sweeney J. Number of instars and sexual dimorphism of Tetropium fuscum (Coleoptera: Cerambycidae) larvae determined by maximum likelihood Canadian Entomologist. 144: 720-726. DOI: 10.4039/tce.2012.60 |
0.015 |
|
| 2000 |
Flaherty L. From the feds Journal of Emergency Nursing: Jen : Official Publication of the Emergency Department Nurses Association. 26: 355-9. PMID 10940847 |
0.014 |
|
| 2000 |
Flaherty L. From the feds Journal of Emergency Nursing: Jen : Official Publication of the Emergency Department Nurses Association. 26: 150-4. PMID 10748391 |
0.014 |
|
| 2000 |
Flaherty L. From the feds Journal of Emergency Nursing: Jen : Official Publication of the Emergency Department Nurses Association. 26: 51-5. PMID 10657800 |
0.014 |
|
| 1999 |
Flaherty L. From the feds Journal of Emergency Nursing: Jen : Official Publication of the Emergency Department Nurses Association. 25: 533-5. PMID 10579782 |
0.014 |
|
| 1999 |
Flaherty L, Snyder JA. From the feds Journal of Emergency Nursing: Jen : Official Publication of the Emergency Department Nurses Association. 25: 302-6. PMID 10424961 |
0.014 |
|
| 1999 |
Flaherty L, Snyder JA. From the feds Journal of Emergency Nursing: Jen : Official Publication of the Emergency Department Nurses Association. 25: 208-11. PMID 10346845 |
0.014 |
|
| 1996 |
Sharar SR, Chapman NN, Flaherty LC, Harlan JM, Tedder TF, Winn RK. L-selectin (CD62L) blockade does not impair peritoneal neutrophil emigration or subcutaneous host defense to bacteria in rabbits. Journal of Immunology (Baltimore, Md. : 1950). 157: 2555-63. PMID 8805657 |
0.013 |
|
| 2003 |
Becker DF, Daley M, Green MR, Hendren RL, Flaherty LT, Gadpaille WJ, Harper G, King RA, Lester P, Onesti SJ, Schwab-Stone M, Wong SW. Introduction to Special Section Adolescent Psychiatry. 27: 137-142. |
0.013 |
|
| 2018 |
Flaherty LM, Schoeppe J, Kruse-Jarres R, Konkle BA. Balance, falls, and exercise: Beliefs and experiences in people with hemophilia: A qualitative study. Research and Practice in Thrombosis and Haemostasis. 2: 147-154. PMID 30046715 DOI: 10.1002/rth2.12060 |
0.013 |
|
| 1996 |
Wade N, Kim H, Scheuermann E, Conroy J, Flaherty L. A sequence comparison of the HIV type 1 rev trans-activator from rapid- and slow-progressor infected infants and children. Aids Research and Human Retroviruses. 12: 845-7. PMID 8738438 |
0.012 |
|
| 1991 |
Flaherty L, Jurkovich GJ. Minor splenic injuries: associated injuries and transfusion requirements. The Journal of Trauma. 31: 1618-21. PMID 1749032 |
0.012 |
|
| 1990 |
Baron NW, Davis LP, Flaherty LE, Muz J, Valdivieso M, Kling GA. Scintigraphic findings in patients with shoulder pain caused by interleukin-2. Ajr. American Journal of Roentgenology. 154: 327-30. PMID 2105025 DOI: 10.2214/ajr.154.2.2105025 |
0.012 |
|
| 1996 |
Flaherty LT, Weist MD, Warner BS. School-based mental health services in the United States: history, current models and needs. Community Mental Health Journal. 32: 341-52. PMID 8840077 DOI: 10.1007/Bf02249452 |
0.011 |
|
| 2013 |
Flaherty LM, Josephson NC. Screening for fall risk in patients with haemophilia. Haemophilia : the Official Journal of the World Federation of Hemophilia. 19: e103-9. PMID 23216824 DOI: 10.1111/hae.12071 |
0.011 |
|
| 2003 |
Becker DF, Daley M, Gadpaille WJ, Green MR, Flaherty LT, Harper G, Hendren RL, King RA, Lester P, Onesti SJ, Schwab-Stone M, Wong SW. Trauma and Adolescence I: The Nature and Scope of Trauma Adolescent Psychiatry. 27: 143-163. |
0.011 |
|
| 2003 |
Becker DF, Daley M, Green MR, Hendren RL, Flaherty LT, Gadpaille WJ, Harper G, King RA, Lester P, Onesti SJ, Schwab-Stone M, Wong SW. Trauma and Adolescence III: Issues of Identification, Intervention, and Social Policy Adolescent Psychiatry. 27: 201-223. |
0.011 |
|
| 2001 |
Flaherty L. Report on the integration of pediatrics into state EMS system Journal of Emergency Nursing. 27: 576-577. |
0.01 |
|
| 1971 |
Mozdzierz GJ, Macchitelli FJ, Flaherty L, DeVito R. Temperament characteristics of chronic alcoholics as measured by the Guilford-Zimmerman temperament survey. The Journal of Psychology. 79: 97-102. PMID 5170854 DOI: 10.1080/00223980.1971.9923773 |
0.01 |
|
| 2015 |
Rappaport N, Pollack WS, Flaherty LT, Schwartz SE, McMickens C. Safety assessment in schools: beyond risk: the role of child psychiatrists and other mental health professionals. Child and Adolescent Psychiatric Clinics of North America. 24: 277-89. PMID 25773324 DOI: 10.1016/j.chc.2014.11.001 |
0.01 |
|
| 2009 |
Flaherty L, Damato EG. Relationships among sleep duration, sleep quality, fatigue, and depression in fathers of twins. Western Journal of Nursing Research. 31: 1094-5. PMID 20008319 DOI: 10.1177/0193945909342554 |
0.01 |
|
| 2008 |
Wagner TD, Wharton K, Donohue K, Sperl ML, Flaherty L, Jaggernauth W, Yap JC, Fernando SA, Landry JC, Yang GY. Pure tubular breast carcinoma: a 34 year study of outcomes. The Breast Journal. 14: 512-3. PMID 18821938 DOI: 10.1111/j.1524-4741.2008.00637.x |
0.01 |
|
| 2007 |
Yang GY, Li B, Wagner TD, Donohue KA, Flaherty L, Kuettel MR. Long-term outcome of stage I seminoma. American Journal of Clinical Oncology. 30: 205-10. PMID 17414472 DOI: 10.1097/01.coc.0000255613.72254.31 |
0.01 |
|
| 2007 |
Rothschild JM, Mann K, Keohane CA, Williams DH, Foskett C, Rosen SL, Flaherty L, Chu JA, Bates DW. Medication safety in a psychiatric hospital. General Hospital Psychiatry. 29: 156-62. PMID 17336665 DOI: 10.1016/j.genhosppsych.2006.12.002 |
0.01 |
|
| 2006 |
Rappaport N, Flaherty LT, Hauser ST. Beyond psychopathology: assessing seriously disruptive students in school settings. The Journal of Pediatrics. 149: 252-6. PMID 16887445 DOI: 10.1016/j.jpeds.2006.03.018 |
0.01 |
|
| 2005 |
Muss HB, Von Roenn J, Damon LE, Deangelis LM, Flaherty LE, Harari PM, Kelly K, Kosty MP, Loscalzo MJ, Mennel R, Mitchell BS, Mortimer JE, Muggia F, Perez EA, Pisters PW, et al. ACCO: ASCO core curriculum outline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2049-77. PMID 15728218 DOI: 10.1200/JCO.2005.99.008 |
0.01 |
|
| 2005 |
Flaherty LM, Riley JE. New frontiers for oil dispersants 2005 International Oil Spill Conference, Iosc 2005. 5141. |
0.01 |
|
| 2003 |
Flaherty LT. Youth, Ideology, and Terrorism Adolescent Psychiatry. 27: 29-58. |
0.01 |
|
| 2001 |
Flaherty L. One out of 10 US residents treated for injuries in the emergency department Journal of Emergency Nursing. 27: 575-576. |
0.01 |
|
| 2001 |
Flaherty L. Fatal and nonfatal firearm-related injuries in the United States, 1993-1998 Journal of Emergency Nursing. 27: 575. |
0.01 |
|
| 2001 |
Flaherty L. Data detailing auto trauma cases available Journal of Emergency Nursing. 27: 577. |
0.01 |
|
| 2000 |
Flaherty L. Department of health and human services Journal of Emergency Nursing. 26: 150-154. DOI: 10.1067/men.2000.106173 |
0.01 |
|
| 1999 |
Holm A, Michel M, Stern GA, Hung TM, Klein T, Flaherty L, Michel S, Maletta G. The outcomes of an inpatient treatment program for geriatric patients with dementia and dysfunctional behaviors. The Gerontologist. 39: 668-76. PMID 10650676 |
0.01 |
|
| 1996 |
Flaherty L. Appropriate use of air bags: a word of caution. Journal of Emergency Nursing: Jen : Official Publication of the Emergency Department Nurses Association. 22: 133-5. PMID 8716302 |
0.01 |
|
| 1996 |
Flaherty L. Neonates and premature infants: overview of differences and ED management. Journal of Emergency Nursing: Jen : Official Publication of the Emergency Department Nurses Association. 22: 120-4. PMID 8716301 |
0.01 |
|
| 1995 |
LoRusso P, Foster BJ, Poplin E, McCormick J, Kraut M, Flaherty L, Heilbrun LK, Valdivieso M, Baker L. Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 1: 1487-93. PMID 9815948 |
0.01 |
|
| 1995 |
Flaherty L. More on getting the word out. Journal of Emergency Nursing: Jen : Official Publication of the Emergency Department Nurses Association. 21: 274-5. PMID 7658621 |
0.01 |
|
| 1992 |
Poplin E, Smith H, Behrens B, Redman B, Flaherty L, Neidhart J, Alberts D. SWOG 8825: melphalan GM-CSF: a phase I study. Gynecologic Oncology. 44: 66-70. PMID 1730428 |
0.01 |
|
| 1991 |
Flaherty LT. State-university collaboration in child and adolescent psychiatry. Hospital & Community Psychiatry. 42: 56-9. PMID 2026404 |
0.01 |
|
| 1989 |
Flaherty LT. A model curriculum for teaching adolescent psychiatry. Adolescent Psychiatry. 16: 491-520. PMID 2817271 |
0.01 |
|
| 1982 |
Flaherty LT. To love and/or to work: the ideological dilemma of young women. Adolescent Psychiatry. 10: 41-51. PMID 7171110 |
0.01 |
|
| 1981 |
Flaherty L, Sarles RM. Psychosis during adolescence. A review. Journal of Adolescent Health Care : Official Publication of the Society For Adolescent Medicine. 1: 301-7. PMID 7037717 DOI: 10.1016/S0197-0070(81)80010-1 |
0.01 |
|
| 1980 |
Kerber CW, Flaherty LW. A teaching and research simulator for therapeutic embolization. Ajnr. American Journal of Neuroradiology. 1: 167-9. PMID 6779597 |
0.01 |
|
| 1970 |
DeVito RA, Flaherty LA, Mozdzierz GJ. Toward a psychodynamic theory of alcoholism. Diseases of the Nervous System. 31: 43-9. PMID 4391783 |
0.01 |
|
| Hide low-probability matches. |